• Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: A study of the Arbeitsgemeinschaft Internistische Onkologie. J Clin Oncol 26:1435-1442, 2008

• Biweekly Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel (FLOT) is Active and has a Favorable Safety Profile for Patients with Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction: a Phase II Trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO). Ann Oncol; Epub May 2008

• A phase I trial of PEGylated glutaminase (PEG-PGA) in combination with 6-diazo-5-oxo-L-norleucine (DON) in advanced, refractory, solid tumors. Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007: 14040

• Interim safety analysis of a randomized phase III study evaluating pegylated liposomal doxorubicin (PLD) versus capecitabine as first line chemotherapy for metastatic breast cancer (MBC): The PELICAN study. Eur J Cancer, 2008 European Breast Cancer Conference, Vol 6 No7 (EJC supplements), 2008: 177

Monitoring (ongoing projects)

• Randomized, single-blinded, phase II study in chronic inflammatory bowel disease

• Randomized phase II trial in older adult patients with gastric cancer

• FLOT3 Trial in patients with esophagogastric cancer

• Phase II trial in patients with gallbladder and bile duct cancer

• Phase I/IIa study in patients with advanced solid tumors 

Manuscript writing/assistance (published projects)

• Reduced incidence of severe palmar-plantar erythrodysesthesia and mucositis in a prospective multicenter phase II trial with pegylated liposomal doxorubicin at 40 mg/m2 every 4 weeks in previously treated patients with metastatic breast cancer. Oncology 2006; 70(2):141-6

• The clinical benefit of pegylated liposomal doxorubicin in patients with metastatic breast cancer previously treated with conventional anthracyclines: a multicentre phase II trial. Br J Cancer 2006 Jun 5; 94(11):1615-20

Manuscript writing/assistance (ongoing projects)

• Meta-analysis in breast cancer patients (project confidential at this stage)

Subcontractor of

• Parexel International GmbH

• Trium Analysis Online GmbH (www.trium.de)

• FGK Clinical Research GmbH

• FLOT Gastric Cancer Study Group  of the AIO (www.flot-studien.de)